Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 14.98
(1.22%)
HKD 14.98
(1.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 19.68 Billion CNY | -4.7% |
| 2022 | 20.78 Billion CNY | 10.68% |
| 2021 | 18.77 Billion CNY | 11.26% |
| 2020 | 16.87 Billion CNY | -0.97% |
| 2019 | 17.04 Billion CNY | 17.1% |
| 2018 | 14.55 Billion CNY | 33.21% |
| 2017 | 10.92 Billion CNY | 38.1% |
| 2016 | 7.91 Billion CNY | 25.55% |
| 2015 | 6.3 Billion CNY | 18.72% |
| 2014 | 5.3 Billion CNY | 19.18% |
| 2013 | 4.45 Billion CNY | 38.55% |
| 2012 | 3.21 Billion CNY | 28.85% |
| 2011 | 2.49 Billion CNY | 58.79% |
| 2010 | 1.57 Billion CNY | 24.51% |
| 2009 | 1.26 Billion CNY | 18.87% |
| 2008 | 1.06 Billion CNY | 6.19% |
| 2007 | 999.48 Million CNY | 21.91% |
| 2006 | 819.83 Million CNY | -10.15% |
| 2005 | 912.49 Million CNY | 17.96% |
| 2004 | 773.58 Million CNY | 30.99% |
| 2003 | 590.54 Million CNY | 62.44% |
| 2002 | 363.55 Million CNY | 30.31% |
| 2001 | 278.98 Million CNY | 2.61% |
| 2000 | 271.88 Million CNY | 40.12% |
| 1999 | 194.03 Million CNY | 48.03% |
| 1998 | 131.07 Million CNY | 77.41% |
| 1997 | 73.88 Million CNY | 170.23% |
| 1996 | 27.34 Million CNY | 87.93% |
| 1995 | 14.54 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.91 Billion CNY | -3.14% |
| 2024 Q3 | 5.02 Billion CNY | 2.09% |
| 2024 Q1 | 5.07 Billion CNY | 4.01% |
| 2023 FY | 19.8 Billion CNY | -4.7% |
| 2023 Q1 | 5.57 Billion CNY | -8.29% |
| 2023 Q2 | 5.12 Billion CNY | -8.16% |
| 2023 Q3 | 4.22 Billion CNY | -17.51% |
| 2023 Q4 | 4.88 Billion CNY | 15.62% |
| 2022 Q4 | 6.07 Billion CNY | 23.13% |
| 2022 Q1 | 4.52 Billion CNY | -11.54% |
| 2022 Q2 | 5.24 Billion CNY | 15.99% |
| 2022 Q3 | 4.93 Billion CNY | -5.83% |
| 2022 FY | 20.78 Billion CNY | 10.68% |
| 2021 Q1 | 4.23 Billion CNY | -6.53% |
| 2021 Q2 | 4.6 Billion CNY | 8.93% |
| 2021 Q3 | 4.82 Billion CNY | 4.67% |
| 2021 Q4 | 5.11 Billion CNY | 5.93% |
| 2021 FY | 18.77 Billion CNY | 11.26% |
| 2020 Q3 | 4.53 Billion CNY | -0.75% |
| 2020 Q2 | 4.57 Billion CNY | 40.98% |
| 2020 Q4 | 4.52 Billion CNY | -0.18% |
| 2020 Q1 | 3.24 Billion CNY | -25.49% |
| 2020 FY | 16.87 Billion CNY | -0.97% |
| 2019 FY | 17.04 Billion CNY | 17.1% |
| 2019 Q3 | 4.11 Billion CNY | -10.39% |
| 2019 Q2 | 4.59 Billion CNY | 15.48% |
| 2019 Q4 | 4.35 Billion CNY | 5.67% |
| 2019 Q1 | 3.97 Billion CNY | -0.05% |
| 2018 Q2 | 3.61 Billion CNY | 9.88% |
| 2018 Q4 | 3.98 Billion CNY | 8.8% |
| 2018 FY | 14.55 Billion CNY | 33.21% |
| 2018 Q1 | 3.29 Billion CNY | -1.88% |
| 2018 Q3 | 3.65 Billion CNY | 1.1% |
| 2017 Q4 | 3.35 Billion CNY | 20.47% |
| 2017 Q3 | 2.78 Billion CNY | 5.8% |
| 2017 Q1 | 2.14 Billion CNY | -1.84% |
| 2017 FY | 10.92 Billion CNY | 38.1% |
| 2017 Q2 | 2.63 Billion CNY | 22.65% |
| 2016 Q2 | 2.04 Billion CNY | 22.62% |
| 2016 FY | 7.91 Billion CNY | 25.55% |
| 2016 Q4 | 2.18 Billion CNY | 8.6% |
| 2016 Q3 | 2.01 Billion CNY | -1.38% |
| 2016 Q1 | 1.66 Billion CNY | -2.36% |
| 2015 FY | 6.3 Billion CNY | 18.72% |
| 2015 Q4 | 1.7 Billion CNY | 6.46% |
| 2015 Q3 | 1.6 Billion CNY | -0.53% |
| 2015 Q2 | 1.61 Billion CNY | 16.67% |
| 2015 Q1 | 1.38 Billion CNY | -10.97% |
| 2014 FY | 5.3 Billion CNY | 19.18% |
| 2014 Q4 | 1.55 Billion CNY | 10.47% |
| 2014 Q3 | 1.4 Billion CNY | 12.4% |
| 2014 Q2 | 1.24 Billion CNY | 13.28% |
| 2014 Q1 | 1.1 Billion CNY | -17.7% |
| 2013 Q2 | 1.08 Billion CNY | 18.28% |
| 2013 FY | 4.45 Billion CNY | 38.55% |
| 2013 Q1 | 913.98 Million CNY | 9.94% |
| 2013 Q3 | 1.11 Billion CNY | 3.43% |
| 2013 Q4 | 1.33 Billion CNY | 19.84% |
| 2012 Q1 | 746.03 Million CNY | -4.25% |
| 2012 Q2 | 813.4 Million CNY | 9.03% |
| 2012 Q4 | 831.35 Million CNY | 0.99% |
| 2012 FY | 3.21 Billion CNY | 28.85% |
| 2012 Q3 | 823.18 Million CNY | 1.2% |
| 2011 Q3 | 643.27 Million CNY | 13.21% |
| 2011 Q1 | 503.76 Million CNY | 16.73% |
| 2011 Q2 | 568.2 Million CNY | 12.79% |
| 2011 FY | 2.49 Billion CNY | 58.79% |
| 2011 Q4 | 779.14 Million CNY | 21.12% |
| 2010 FY | 1.57 Billion CNY | 24.51% |
| 2010 Q1 | 342.42 Million CNY | 4.68% |
| 2010 Q3 | 402.5 Million CNY | 2.06% |
| 2010 Q2 | 394.37 Million CNY | 15.17% |
| 2010 Q4 | 431.55 Million CNY | 7.22% |
| 2009 Q2 | 324.92 Million CNY | 17.53% |
| 2009 Q4 | 327.1 Million CNY | -1.8% |
| 2009 Q3 | 333.11 Million CNY | 2.52% |
| 2009 Q1 | 276.45 Million CNY | 10.71% |
| 2009 FY | 1.26 Billion CNY | 18.87% |
| 2008 Q4 | 249.71 Million CNY | -11.29% |
| 2008 Q3 | 281.49 Million CNY | 2.72% |
| 2008 Q2 | 274.03 Million CNY | 7.0% |
| 2008 Q1 | 256.11 Million CNY | -8.95% |
| 2008 FY | 1.06 Billion CNY | 6.19% |
| 2007 Q2 | 257.84 Million CNY | 17.88% |
| 2007 FY | 999.48 Million CNY | 21.91% |
| 2007 Q4 | 281.28 Million CNY | 16.42% |
| 2007 Q1 | 218.74 Million CNY | -1.92% |
| 2007 Q3 | 241.6 Million CNY | -6.3% |
| 2006 Q1 | 206.92 Million CNY | -13.17% |
| 2006 Q2 | 204.23 Million CNY | -1.3% |
| 2006 Q3 | 185.65 Million CNY | -9.1% |
| 2006 Q4 | 223.02 Million CNY | 20.13% |
| 2006 FY | 819.83 Million CNY | -10.15% |
| 2005 Q3 | 205.45 Million CNY | -16.47% |
| 2005 Q4 | 238.31 Million CNY | 16.0% |
| 2005 Q1 | 222.75 Million CNY | 67.28% |
| 2005 FY | 912.49 Million CNY | 17.96% |
| 2005 Q2 | 245.95 Million CNY | 10.42% |
| 2004 FY | 773.58 Million CNY | 30.99% |
| 2004 Q4 | 133.16 Million CNY | -47.67% |
| 2004 Q1 | 198.67 Million CNY | 20.59% |
| 2004 Q2 | 187.28 Million CNY | -5.74% |
| 2004 Q3 | 254.45 Million CNY | 35.87% |
| 2003 Q4 | 164.76 Million CNY | 18.35% |
| 2003 Q3 | 139.21 Million CNY | -4.36% |
| 2003 Q2 | 145.56 Million CNY | 3.24% |
| 2003 Q1 | 141 Million CNY | 68.93% |
| 2003 FY | 590.54 Million CNY | 62.44% |
| 2002 Q3 | 86.14 Million CNY | -23.87% |
| 2002 Q2 | 113.16 Million CNY | 40.09% |
| 2002 Q1 | 80.77 Million CNY | 0.0% |
| 2002 Q4 | 83.46 Million CNY | -3.11% |
| 2002 FY | 363.55 Million CNY | 30.31% |
| 2001 FY | 278.98 Million CNY | 2.61% |
| 2000 FY | 271.88 Million CNY | 40.12% |
| 1999 FY | 194.03 Million CNY | 48.03% |
| 1998 FY | 131.07 Million CNY | 77.41% |
| 1997 FY | 73.88 Million CNY | 170.23% |
| 1996 FY | 27.34 Million CNY | 87.93% |
| 1995 FY | 14.54 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -11655.472% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | -201.697% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -68293.244% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -4885.371% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 55384.362% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -3470.198% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -1178.697% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -4076.369% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -8985.991% |
| SSY Group Limited | 3.48 Billion HKD | -464.112% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -6062.15% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -3072.23% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 54.613% |